相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ezetimibe for the Treatment of Nonalcoholic Steatohepatitis: Assessment by Novel Magnetic Resonance Imaging and Magnetic Resonance Elastography in a Randomized Trial (MOZART Trial)
Rohit Loomba et al.
HEPATOLOGY (2015)
The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial
Yumie Takeshita et al.
DIABETOLOGIA (2014)
Free Cholesterol Accumulation in Hepatic Stellate Cells: Mechanism of Liver Fibrosis Aggravation in Nonalcoholic Steatohepatitis in Mice
Kengo Tomita et al.
HEPATOLOGY (2014)
Efficacy of ezetimibe for reducing serum low-density lipoprotein cholesterol levels resistant to lifestyle intervention in patients with non-alcoholic fatty liver disease
Noriko Oza et al.
HEPATOLOGY RESEARCH (2014)
Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent
Lay T. Gan et al.
JOURNAL OF HEPATOLOGY (2014)
Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis
Christopher Savard et al.
HEPATOLOGY (2013)
Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews
Rebecca M. Turner et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2012)
Atorvastatin and Antioxidants for the Treatment of Nonalcoholic Fatty Liver Disease: The St Francis Heart Study Randomized Clinical Trial
Temitope Foster et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
Hyohun Park et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Treatment with insulin sensitizer metformin improves arterial properties, metabolic parameters, and liver function in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial
Elena Sofer et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet
Dick C. Chan et al.
DIABETES CARE (2010)
Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: An open-label, pilot study
Masato Yoneda et al.
HEPATOLOGY RESEARCH (2010)
NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease
Munechika Enjoji et al.
LIPIDS IN HEALTH AND DISEASE (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
NAFLD as a Risk Factor for the Development of Diabetes and the Metabolic Syndrome: An Eleven-Year Follow-up Study
Leon A. Adams et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Palmitate Induces Insulin Resistance in H4IIEC3 Hepatocytes through Reactive Oxygen Species Produced by Mitochondria
Seiji Nakamura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease
Yuichi Nozaki et al.
JOURNAL OF HEPATOLOGY (2009)
Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis
Kristiaan Wouters et al.
HEPATOLOGY (2008)
Hepatic steatosis rather than visceral adiposity is more closely associated with insulin resistance in the early stage of obesity
Taro Wasada et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
The Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective
Mariana Lazo et al.
SEMINARS IN LIVER DISEASE (2008)
Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome
Michiyo Deushi et al.
FEBS LETTERS (2007)
Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet
Naoto Matsuzawa et al.
HEPATOLOGY (2007)
Absence of exendin-4 effects on postprandial glucose and lipids in the Gila monster, Heloderma suspectum
Carolyn M. Christel et al.
JOURNAL OF COMPARATIVE PHYSIOLOGY B-BIOCHEMICAL SYSTEMS AND ENVIRONMENTAL PHYSIOLOGY (2007)
Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis
Montserrat Mari et al.
CELL METABOLISM (2006)
Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos Nutrition and Liver Study
G Bedogni et al.
HEPATOLOGY (2005)
The target of ezetimibe is Niemann-Pick Cl-Like 1 (NPC1L1)
M Garcia-Calvo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Plasma transforming growth factor-β1 level and efficacy of α-tocopherol in patients with non-alcoholic steatohepatitis:: a pilot study
T Hasegawa et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
分享论文
